More Funds On The Way For Yaz Blood Clot Victims

The Yaz Resource Center is the Web’s largest source for information on Yaz research, side effects and legal news. Visit http://www.YazLawsuit.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz settlement
Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

(PRWEB) August 09, 2012

The Yaz Resource Center, a patient advocacy group, is alerting those women who took the birth control drugs Yaz or Yasmin that the maker of the drugs, Bayer, has reported they will pledge additional funds to resolve lawsuits filed by patients suffering injuries. However, only certain cases may qualify and the time to file a claim is limited.

Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

Last year, the British Medical Journal released a study from The University of Copenhagen on October 25th that linked the chemical in Yaz to blood clots. Two days later, the FDA released a report titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which also showed drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

The Institute for Safe Medicine Practices’ QuarterWatch released a study on May 31, 2012 which ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA, with more than 8,000 total side effect complaints.

Due to the volume of Yaz lawsuits that patients have filed, a federal panel established a Multi-District Litigation court in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates more than 10,000 patients have filed a claim so far.

Bloomberg News originally reported on April 13th that Bayer had begun settling Yaz lawsuits for approximately $220,000 per case. The company confirmed this in its’ 2012 first quarter Stockholders’ Newsletter, stating it had paid $142 million to settle over 600 Yaz cases.

Now, Bloomberg last reported on July 31st that Bayer has settled nearly 1900 Yaz lawsuits for more than $400 million, at an average of around $212,000. The article also indicates Bayer has more than doubled its reserves for settling these cases to over $610 million, which could be positive news for those affected by the drug who have yet to file a claim.

Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible and find out if a Yaz lawsuit is a possibility.

The Yaz Resource Center cautions that only certain cases may be eligible for a Yaz settlement. Victims should make sure they choose a lawyer with experience in defective drug litigation. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.


Contact